Nosopharm, a company dedicated to the research and development of new anti-infective drugs, and the University of Illinois at Chicago (UIC) today announce the publication of a study in Molecular ...

New antibiotics are crucial in the fight against antimicrobial resistance. Assessing the effectiveness of new antibiotics requires standardised high-quality infection models, readily available to ...

The heartburn drugs in question included both proton pump inhibitors (PPIs) -- brands like Prilosec, Prevacid and Nexium -- and H2 blockers, such as Zantac, Pepcid and Tagamet, the study authors said.

More information: Johny Nguyen et al, A review of antibiotic safety in pregnancy—2025 update, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy (2025). DOI: 10.1002/phar.70010 ...

Traditional targets for antibiotics are limited; no new antibiotics have been discovered since 1987. Only 2 antibiotics have received US FDA approval since 2009.

Of 118 different formulations of FDCs being sold in India between 2007 and 2012, the team found that 64 per cent (75) were not approved by the national drugs regulator, the Central Drugs Standard ...

Bacteriophages, or simply phages, are viruses that infect and replicate within bacteria, and they hold considerable potential for combatting antibiotic-resistance and other threats to human health.